Literature DB >> 34981503

Naturally Occurring SGLT2 Inhibitors: A Review.

Habib Yaribeygi1, Milad Ashrafizadeh2,3, Thozhukat Sathyapalan4, Tannaz Jamialahmadi5,6, Amirhossein Sahebkar7,8,9,10.   

Abstract

With an increasing incidence of diabetes mellitus globally due to various factors, including unhealthy lifestyle, there is a need for developing novel drugs for the management of diabetes. This chronic metabolic disorder results in high blood glucose levels due to the body's inability to reduce the concentration of glucose. The decreased secretion of insulin and increased resistance to insulin action contribute to the development of diabetes mellitus. There have been efforts to target pathways involved in the metabolism of blood glucose. It seems that most of the currently applied antidiabetic medications are associated with unwanted side effects. Hence, it appears that plant-derived chemicals can be considered as potential candidates in the management of diabetes. Sodium-glucose cotransporter inhibitors (SGLT2i) are synthetic hypoglycemic medications approved for managing patients with diabetes in lowering blood glucose. SGLT2i reduces blood glucose concentration by enhancing its urinary excretion and inhibition of its absorption through the kidney. It has been demonstrated that some of the naturally occurring nutraceutical agents can imitate the action of SGLT2i and, consequently, diminish the level of blood glucose. At the present review, we have discussed the phytochemicals that act like SGLT2i to decrease blood glucose level.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Antidiabetic medications; Diabetes; Glucose; Herbal medicine; SGLT2i

Mesh:

Substances:

Year:  2021        PMID: 34981503     DOI: 10.1007/978-3-030-73234-9_37

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  39 in total

Review 1.  Mechanisms of diabetic complications.

Authors:  Josephine M Forbes; Mark E Cooper
Journal:  Physiol Rev       Date:  2013-01       Impact factor: 37.312

2.  Global estimates of diabetes prevalence for 2013 and projections for 2035.

Authors:  L Guariguata; D R Whiting; I Hambleton; J Beagley; U Linnenkamp; J E Shaw
Journal:  Diabetes Res Clin Pract       Date:  2013-12-01       Impact factor: 5.602

3.  Risk of Cause-Specific Death in Individuals With Diabetes: A Competing Risks Analysis.

Authors:  Jose Miguel Baena-Díez; Judit Peñafiel; Isaac Subirana; Rafel Ramos; Roberto Elosua; Alejandro Marín-Ibañez; María Jesús Guembe; Fernando Rigo; María José Tormo-Díaz; Conchi Moreno-Iribas; Joan Josep Cabré; Antonio Segura; Manel García-Lareo; Agustín Gómez de la Cámara; José Lapetra; Miquel Quesada; Jaume Marrugat; Maria José Medrano; Jesús Berjón; Guiem Frontera; Diana Gavrila; Aurelio Barricarte; Josep Basora; Jose María García; Natalia C Pavone; David Lora-Pablos; Eduardo Mayoral; Josep Franch; Manel Mata; Conxa Castell; Albert Frances; María Grau
Journal:  Diabetes Care       Date:  2016-08-04       Impact factor: 19.112

Review 4.  The management of diabetes mellitus-imperative role of natural products against dipeptidyl peptidase-4, α-glucosidase and sodium-dependent glucose co-transporter 2 (SGLT2).

Authors:  Ghulam Abbas; Ahmed Al Harrasi; Hidayat Hussain; Ahmed Hamaed; Claudiu T Supuran
Journal:  Bioorg Chem       Date:  2019-02-04       Impact factor: 5.275

5.  Diabetes, lower-extremity amputation, and death.

Authors:  Ole Hoffstad; Nandita Mitra; Jonathan Walsh; David J Margolis
Journal:  Diabetes Care       Date:  2015-07-22       Impact factor: 19.112

Review 6.  Natural Products as Lead Compounds for Sodium Glucose Cotransporter (SGLT) Inhibitors.

Authors:  Wolfgang Blaschek
Journal:  Planta Med       Date:  2017-04-10       Impact factor: 3.352

Review 7.  Apoptosis in pancreatic β-islet cells in Type 2 diabetes.

Authors:  Tatsuo Tomita
Journal:  Bosn J Basic Med Sci       Date:  2016-05-22       Impact factor: 3.363

8.  Fenofibrate improves renal function by amelioration of NOX-4, IL-18, and p53 expression in an experimental model of diabetic nephropathy.

Authors:  Habib Yaribeygi; Mohammad T Mohammadi; Ramin Rezaee; Amirhossein Sahebkar
Journal:  J Cell Biochem       Date:  2018-05-15       Impact factor: 4.429

9.  Complications of Diabetes 2016.

Authors:  Konstantinos Papatheodorou; Nikolaos Papanas; Maciej Banach; Dimitrios Papazoglou; Michael Edmonds
Journal:  J Diabetes Res       Date:  2016-10-16       Impact factor: 4.011

10.  Increased Glucose Transport into Neurons Rescues Aβ Toxicity in Drosophila.

Authors:  Teresa Niccoli; Melissa Cabecinha; Anna Tillmann; Fiona Kerr; Chi T Wong; Dalia Cardenes; Alec J Vincent; Lucia Bettedi; Li Li; Sebastian Grönke; Jacqueline Dols; Linda Partridge
Journal:  Curr Biol       Date:  2016-08-11       Impact factor: 10.834

View more
  1 in total

Review 1.  From Bench to Bedside in Precision Medicine: Diabetes Mellitus and Peri-Implantitis Clinical Indices with a Short-Term Follow-Up: A Systematic Review and Meta-Analysis.

Authors:  Mario Dioguardi; Stefania Cantore; Salvatore Scacco; Cristian Quarta; Diego Sovereto; Francesca Spirito; Mario Alovisi; Giuseppe Troiano; Riccardo Aiuto; Daniele Garcovich; Vito Crincoli; Luigi Laino; Michele Covelli; Annarita Malcangi; Lorenzo Lo Muzio; Andrea Ballini; Michele Di Cosola
Journal:  J Pers Med       Date:  2022-02-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.